BioAge Labs Inc. (BIOA) vs Compugen Ltd. (CGEN)
A side-by-side comparison of BioAge Labs Inc. and Compugen Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIOA
BioAge Labs Inc.
$6.27HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
CGEN
Compugen Ltd.
$2.24HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — BIOA vs CGEN
growth of $100 · dividends reinvested · last 2yBIOA -65.3% (-41.1%/yr)CGEN +21.6% (+10.3%/yr)CGEN compounded faster over this window
BIOA CGEN
BIOA vs CGEN: by the numbers
- •BIOA is the larger company ($236M vs $212M market cap).
- •CGEN is profitable (47.55% net margin) while BIOA runs a net loss (-912.25%).
Metrics side by side
Valuation
| Metric | BIOA | CGEN |
|---|---|---|
| P/E ratio | N/A | 5.96 |
| P/S ratio | 22.80 | 2.86 |
| P/B ratio | 0.63 | 2.39 |
Profitability
| Metric | BIOA | CGEN |
|---|---|---|
| Gross margin | 99.39% | 86.89% |
| Operating margin | -1026.28% | 40.94% |
| Net margin | -912.25% | 47.55% |
| ROE | -25.20% | 39.66% |
| ROIC | -28.14% | 26.14% |
Growth (annualized)
| Metric | BIOA | CGEN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 105.91% |
| Total return CAGR (5Y) | N/A | -18.39% |
Frequently asked
- Is BIOA or CGEN more profitable?
- CGEN runs the higher net margin — BIOA at -912.25% versus CGEN at 47.55%.
Go deeper
Dig into the metrics
Compugen P/E ratioBioAge Labs ROECompugen ROEBioAge Labs operating marginCompugen operating marginBioAge Labs revenue growthCompugen revenue growthBioAge Labs free cash flowCompugen free cash flow
BioAge Labs & Compugen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.